HEATHER BAILEY: Open Payments
NPI 1417058298 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 42 payments from 18 companies in 2025. Trend: 2023 $507 · 2024 $340 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Abbott Laboratories | 3 | $80 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| PFIZER INC. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $35 |
| Corcept Therapeutics | 2 | $33 |
Products named: TRELEGY ELLIPTA, CAPLYTA, FREESTYLE LIBRE 3, SHINGRIX, CAPVAXIVE, Ozempic, VOQUEZNA, Korlym.
Industry payments across NY — which companies pay providers there.
